BFRI - MCAP CO - Biofrontera Inc.

Biofrontera Inc. (BFRI) is a recognized leader in skin oncology therapy, whose authority among medical professionals is built on the safety of its treatment methods. Strict drug application protocols guarantee sustained demand and high profitability for consumables. The sale of photodynamic therapy agents generates a stable cash flow, ensuring robust margins. The market capitalization stands at 0.02, which is clearly reflected in the company's price action.

The market capitalization of the issuer reflects the value of Biofrontera Inc. (BFRI), accounting for investments in the eco-friendly synthesis of dermatological products. This metric is calculated as the product of the current share price and the total number of outstanding securities. It measures the aggregate market value of the business in real-time. This price action reflects the market discounting of the company's achievements in zero-waste technologies. Investors should view this trend as an indicator of confidence in the long-term development strategy.